TY  - GEN
AU  - Haas,D W
AU  - Arathoon,E
AU  - Thompson,M A
AU  - de Jesus Pedro,R
AU  - Gallant,J E
AU  - Uip,D E
AU  - Currier,J
AU  - Noriega,L M
AU  - Lewi,D S
AU  - Uribe,P
AU  - Benetucci,L
AU  - Cahn,P
AU  - Paar,D
AU  - White,A C
AU  - Collier,A C
AU  - Ramirez-Ronda,C H
AU  - Harvey,C
AU  - Chung,M O
AU  - Mehrotra,D
AU  - Chodakewitz,J
AU  - Nguyen,B Y
TI  - Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine
SN  - 0269-9370
PY  - 2001///0208
KW  - Adult
KW  - Anti-HIV Agents
KW  - adverse effects
KW  - Antiretroviral Therapy, Highly Active
KW  - CD4 Lymphocyte Count
KW  - Drug Administration Schedule
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - isolation & purification
KW  - Humans
KW  - Indinavir
KW  - administration & dosage
KW  - Lamivudine
KW  - Pilot Projects
KW  - RNA, Viral
KW  - blood
KW  - Reverse Transcriptase Inhibitors
KW  - Treatment Outcome
KW  - Viral Load
KW  - Zidovudine
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/00002030-200009080-00013
ER  -